Wiinberg Ulf
- SEC CIK
- 0001187314
No open-market purchases or sales filed in the past year.
Current role at each company
- INKT MiNK Therapeutics, Inc.Directoras of Sep 2, 2026
- AGEN Agenus IncDirectoras of Oct 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wiinberg Ulf as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGEN Agenus Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Wiinberg UlfDirector | PPurchase | +25.0K | $0.76 | +$19.0K | +25.2%124.1K after |
INKT MiNK Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2022 (view filing) | Jul 18-19 | 3 daysLate | Wiinberg UlfDirector | PPurchase | +20.0K | $1.38 | +$27.6K | +7.2%298.3K after | 2 lots |